Provided by Tiger Trade Technology Pte. Ltd.

Qiagen NV

41.65
+0.68501.67%
Volume:190.02K
Turnover:7.91M
Market Cap:8.58B
PE:20.39
High:41.90
Open:41.80
Low:41.38
Close:40.96
52wk High:57.82
52wk Low:38.80
Shares:206.00M
Float Shares:204.03M
Volume Ratio:0.60
T/O Rate:0.09%
Dividend:0.26
Dividend Rate:0.63%
EPS(TTM):2.04
EPS(LYR):2.04
ROE:11.57%
ROA:5.77%
PB:2.27
PE(LYR):20.39

Loading ...

How Investors May Respond To Qiagen (QGEN) Entering Rapid Bloodstream Infection Testing With New Panel

Simply Wall St.
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM) and Qiagen (QGEN)

TIPRANKS
·
Apr 15

Qiagen expands into bloodstream infection syndromic testing

TIPRANKS
·
Apr 15

Is Qiagen (QGEN) Offering Value After Mixed Share Price Performance?

Simply Wall St.
·
Apr 14

Qiagen price target raised to EUR 44 from EUR 43 at Morgan Stanley

TIPRANKS
·
Apr 14

Qiagen Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
Apr 14

Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48

MT Newswires Live
·
Apr 14

How Investors May Respond To Qiagen (QGEN) Upgrade After Reaffirmed 5% Outlook And New Product Plans

Simply Wall St.
·
Apr 07

Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection

Simply Wall St.
·
Mar 28

Qiagen : Deutsche Bank Raises to Buy From Hold

THOMSON REUTERS
·
Mar 13

Qiagen (QGEN) Valuation Check After Recent Share Price Weakness

Simply Wall St.
·
Mar 12

QIAGEN Gets US FDA Clearance for Gastrointestinal Panels on Automated Syndromic Platform

MT Newswires Live
·
Mar 11

Qiagen says ‘convinced’ strategic alternatives review ‘good for shareholders’

TIPRANKS
·
Mar 03

Analysts Are Bullish on These Healthcare Stocks: CG Oncology, Inc. (CGON), Qiagen (QGEN)

TIPRANKS
·
Feb 20

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Foghorn Therapeutics (FHTX)

TIPRANKS
·
Feb 18

UBS Adjusts QIAGEN Price Target to $52 From $50, Maintains Neutral Rating

MT Newswires Live
·
Feb 09

Qiagen Is Maintained at Neutral by Citigroup

Dow Jones
·
Feb 07

Qiagen price target raised to $53 from $48.42 at Baird

TIPRANKS
·
Feb 06

Qiagen Nv : TD Cowen Raises Target Price to $53 From $48

THOMSON REUTERS
·
Feb 06

Qiagen price target raised to $59 from $57 at Jefferies

TIPRANKS
·
Feb 06